GPER, whose action differs from the classical nuclear estrogen receptors (ERα, ERβ), acts as an independent ER in breast cancer cells and has been implicated in mediating both rapid and transcriptional events in response to estrogen under certain circumstances [16, 24, 38]. This evidence concerns the gene ESR2 and breast carcinoma.